NASDAQ
ADMA Biologics, Inc. (ADMA) has a current ratio of 6.71x as of Monday, May 25, 2026. This represents a 7.83% increase compared to its 12-month average of 6.22x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.